Gerald B. Pier
Founder bij Alopexx Enterprises LLC
Profiel
Gerald B.
Pier was the founder of Alopexx, Inc. (founded in 2019) and served as the Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Currently, Dr. Pier is a Professor at Harvard Medical School.
In terms of education, Dr. Pier holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of the Pacific.
Actieve functies van Gerald B. Pier
| Bedrijven | Functie | Begin |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Founder | - |
Eerdere bekende functies van Gerald B. Pier
| Bedrijven | Functie | Einde |
|---|---|---|
| ALOPEXX, INC. | Founder | - |
Opleiding van Gerald B. Pier
| University of California, Berkeley | Doctorate Degree |
| University of the Pacific | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
